Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can The Bridge Facilitate Successful Transition From Medication-Assisted Treatment (MAT) With Low-dose Sublingual Buprenorphine to Oral Naltrexone in Patients With Extended Remission of Opiate Use Disorder

NCT03762798 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT03762798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03762798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can The Bridge Facilitate Successful Transition From Medication-Assisted Treatment (MAT) With Low-dose Sublingual Buprenorphine to Oral Naltrexone in Patients With Extended Remission of Opiate Use Disorder
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Withdrawn
Start date
November 19, 2018
Completion date
December 1, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

substance abuse, substance dependence, substance use, substance use disorders